Jayam Krishna-Iyer, M.D.; Suspension of Registration; Granting of Renewal Application Subject to Condition, 459-464 [E8-31412]
Download as PDF
Federal Register / Vol. 74, No. 3 / Tuesday, January 6, 2009 / Notices
the usual course of professional
practice. See 21 U.S.C. 802(21) (‘‘The
term ‘practitioner’ means a physician
* * * licensed, registered, or otherwise
permitted, by * * * the jurisdiction in
which he practices * * * to * * *
dispense * * * a controlled
substance.’’); United States v. Moore,
423 U.S. 122, 140–41 (1975) (‘‘In the
case of a physician, the [CSA]
contemplates that he is authorized by
the State to practice medicine and to
dispense drugs in connection with his
professional practice.’’); see also United
Prescription Services, Inc., 72 FR 50397,
50407 (2007) (‘‘[A] physician who
engages in the unauthorized practice of
medicine under state laws is not a
‘practitioner acting in the usual course
of * * * professional practice’ under
the CSA.’’).
I therefore conclude that Mr. Dailey’s/
Powermedica’s experience in
dispensing controlled substances (factor
two) and his/its record of noncompliance with applicable Federal and
State laws (factor four) amply
demonstrate that granting Respondent’s
application for a new registration would
be ‘‘inconsistent with the public
interest.’’ 21 U.S.C. 823(f).5
Accordingly, Respondent’s application
will be denied.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f), as well as 28 CFR
0.100(b) & 0.104, I order that the
application of Wonderyears, Inc., for a
DEA Certificate of Registration as a
retail pharmacy be, and it hereby is,
denied. This Order is effective February
5, 2009.
Dated: December 19, 2008.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E8–31414 Filed 1–5–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 03–8]
mstockstill on PROD1PC66 with NOTICES
Jayam Krishna-Iyer, M.D.; Suspension
of Registration; Granting of Renewal
Application Subject to Condition
On September 1, 2006, I, the Deputy
Administrator of the Drug Enforcement
Administration, ordered that the DEA
Certificate of Registration issued to
Jayam Krishna-Iyer, M.D. (Respondent),
of Clearwater, Florida, be revoked.
5 In light of my findings with respect to factors
two and four, I conclude that it is unnecessary to
make findings with respect to the remaining factors.
VerDate Nov<24>2008
16:52 Jan 05, 2009
Jkt 217001
Jayam Krishna-Iyer, M.D., 71 FR 52148,
52159 (2006). The Order also denied
Respondent’s pending application for
renewal of her registration.
As grounds for the Order, I noted that
Respondent had issued prescriptions for
controlled substances to three separate
undercover operatives notwithstanding
that each of the operatives had indicated
that he was not in pain, and had told
Respondent that he was obtaining
controlled substances from nonlegitimate sources such as friends. Id. at
52158. I further noted that Respondent
had failed to conduct a physical exam
on each of the undercover operatives
and had falsified each operative’s
medical record to indicate that she had
done an exam. Id. I also noted that
Respondent had made statements
during each operative’s visit indicating
that she knew that the operative was
seeking the drugs to abuse them and not
to treat pain. Id. Finally, I noted that
Respondent had pre-signed
prescriptions and given them to a
registered nurse in her employ, and that
she allowed the nurse to issue
prescriptions to one of the operatives
even though she did not attend to the
operative during the visit and the nurse
lacked authority under both Federal law
and Florida law to prescribe controlled
substances. Id.
In the decision, I noted that
Respondent had undertaken substantial
measures to reform her practice
including hiring a private investigation
firm to review patient records to
determine which patients were likely
substance abusers and should be
discharged from her practice; the firm
also developed procedures for
recognizing drug abusers, doctor
shoppers, prescription fraud, patients
with a drug-related criminal history,
and dealing with claims of lost and
stolen medications. Id. at 52156. I also
noted that the firm had conducted
extensive criminal history checks on
Respondent’s patients and that she had
discharged a large of number of patients.
Id.
While I recognized the substantial
measures that Respondent had
undertaken to reform her practice, I
adopted the ALJ’s finding that
Respondent failed to accept
responsibility for her misconduct based
on her testimony that she did not
intentionally or knowingly distribute a
controlled substance to the undercover
operatives because she knew the drugs
would not be sold on the street. Id. at
52159. As I explained in the Order, ‘‘[i]t
is no less a violation that the ‘patient’
will personally use the drug rather than
sell it on the street.’’ Id. I further
concluded that because Respondent had
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
459
‘‘refuse[d] to acknowledge her
responsibilities under the law,’’ the
reforms she had undertaken would ‘‘still
not adequately protect public health and
safety,’’ and that this finding was
dispositive as to whether her continued
registration would be consistent with
the public interest. Id.
Thereafter, Respondent filed a
petition for review in the U.S. Court of
Appeals for the Eleventh Circuit. On
September 25, 2007, following briefing
and oral argument, the Court vacated
the Agency’s Order in an unpublished
opinion. Krishna-Iyer v. DEA, No. 06–
15034 (11th Cir. 2007), Slip Op. at 3.
The Court declared:
In considering Petitioner’s experience in
dispensing controlled substances under
factor 2, the DEA identified only four visits
by three undercover ‘patient,’ who were all
attempting to make a case against her. The
DEA failed to consider Petitioner’s
experience with twelve patients whose
medical charts were seized by the DEA, or
with thousands of other patients. In short, the
DEA did not consider any of Petitioner’s
positive experience in dispensing controlled
substances. This is an arbitrary and unfair
analysis of Petitioner’s experience.
Id. The Court therefore vacated the
Order and remanded the case for
reconsideration, directing that ‘‘DEA
should pay particular attention to the
entire corpus of Petitioner’s record in
dispensing controlled substances, not
only the experience of [the] undercover
officer.’’ Id. The Court further ordered
that ‘‘[t]he five factors should * * * be
re-balanced.’’ Id.
On September 15, 2008, the Parties
submitted a joint motion which
proposed a resolution of the matter.
More specifically, the Parties propose
that I ‘‘issue a new final Order
consistent with the direction of the
* * * Court of Appeals.’’ Joint Motion
at 2. The Parties also request that were
I to find that ‘‘revocation or suspension
is still an appropriate outcome,’’ that the
sanction be limited ‘‘to suspension of
[her] registration for the time’’ that the
Final Order remained in effect. The
Parties also requested that I direct that
Respondent’s pending renewal
application be acted upon
expeditiously. Finally, the Parties
represented that if I concurred with
their proposed resolution, they would
enter into a Memorandum of Agreement
(MOA) under which Respondent’s
registration will be renewed subject to
the condition that for a one year period,
she file monthly reports with the
Agency’s Miami Field Division
providing information regarding her
prescribing of controlled substances.
Attached to the Joint Motion was
Respondent’s statement. In her
E:\FR\FM\06JAN1.SGM
06JAN1
460
Federal Register / Vol. 74, No. 3 / Tuesday, January 6, 2009 / Notices
statement, Respondent: (1)
‘‘Acknowledge[d] wrongdoing for failing
to conduct physical examinations of the
three undercover patients in this case’’;
(2) ‘‘acknowledge[d] wrongdoing for
improperly indicating on the charts of
the undercover patients that she had
conducted a physical examination of’’
them; and (3) ‘‘acknowledge[d] that she
had presigned various prescriptions and
* * * understands that this was
improper.’’ Respondent’s Statement at 1.
Respondent also apologized for her
conduct with respect to each of the
above actions and promises that she will
not engage in similar conduct in the
future.1 Id.
Respondent also stated that she has
reviewed the Agency’s earlier decision,
that she ‘‘has reexamined her conduct
with respect to the three undercover
patients in light of the [Agency’s]
decision and has re-evaluated the
transcripts of the visits of the
undercover patients in light of the
* * * decision.’’ Id. Respondent further
stated that ‘‘she regret[ed] that she
prescribed the medications which she
prescribed to the undercover patients’’
and ‘‘apologized * * * for her
conduct.’’ Id. Respondent also promised
that ‘‘such conduct has not occurred
since [the undercover visits] and will
not occur again.’’ 2
mstockstill on PROD1PC66 with NOTICES
Findings
I incorporate by reference my findings
of fact contained in the original order
and found at pages 71 FR at 52149–56.
As previously found, and as Respondent
acknowledges, she issued controlled
substance prescriptions to three
undercover operatives without
performing physical examinations on
them and falsified medical records to
indicate that she had performed a
physical exam. Moreover, Respondent
prescribed controlled substances to the
undercover operatives even though each
of them represented that they were not
in pain and were obtaining the drugs
from non-legitimate sources such as
friends or family members. Moreover,
during each of the visits, Respondent
made statements that indicated that she
knew the patients were seeking the
1 With respect to the pre-signing of prescriptions,
Respondent stated that ‘‘she had not engaged in
such conduct since being advised by the DEA that
such conduct was improper and promises that she
will not in the future.’’ Respondent’s Statement at
1.
2 Respondent also expressed regret and
apologized for doctor-shopping and inappropriate
diversion of drugs at her clinic. Respondent’s
Statement at 2. I acknowledge (as I did in the
original decision) the extensive efforts Respondent
has undertaken to prevent the diversion and abuse
of drugs by her patients. I also acknowledge
Respondent’s successful completion of the one-year
period of monitoring of her practice.
VerDate Nov<24>2008
16:52 Jan 05, 2009
Jkt 217001
drugs to abuse them and not to treat a
legitimate medical condition. See id. at
52150 (Respondent stating during first
undercover visit: ‘‘Lorcet 10/650. See,
this is a shame then that you have to
take the medicine for the habit.’’); id. at
52152 (after acknowledging that second
undercover operative had told her that
he was taking four to five Vicodin a day
even though he did not have pain, and
was taking them because he ‘‘functioned
better,’’ Respondent asked him if he
‘‘want[ed] to go to substance abuse
program or * * * be maintained on the
vicodin?’’); id. (stating to second
undercover operative ‘‘maybe I’m
sympathetic to the people that allow
themselves to slip into drugs’’); id. at
52154 (during visit of third operative,
when asked by her nurse, ‘‘what’s the
source of the pain?,’’ replying: ‘‘I guess
he feels no pain, he just feels better.’’);
id. (stating to third visitor: ‘‘we will not
be supporting just a drug habit’’).
Having reviewed—for a second time—
the twelve patient files that were seized
during the January 26, 2000 search, I
further find that Respondent discharged
five of these patients prior to the search.
More specifically, I find that: (1)
Respondent discharged K.L. on
February 2, 1998, upon her office’s
being notified that she had altered a
prescription; (2) Respondent discharged
R.H. on February 11, 1999, for various
reasons including his having claimed
that his drugs had been lost or stolen,
and his coming in early to obtain new
prescriptions claiming that he was going
out of town; (3) Respondent discharged
J.B. on December 1, 1998, after her office
was notified that she had been arrested
for photocopying prescriptions and
presenting them for filling to multiple
pharmacies; (4) Respondent discharged
R.S. on December 2, 1999, after being
called by his mother who reported that
he was abusing his medications; and (5)
Respondent discharged J.L. on January
24, 2000, after an anonymous caller
reported to Respondent’s office that he
was simultaneously receiving treatment
at a methadone clinic. See RX 21, at 4,
17, 23, 24 & 34
As stated above, the Court of Appeals
vacated the original Order on the
ground that it failed to consider ‘‘any
of’’ what it termed [Respondent’s]
‘‘positive experience in dispensing
controlled substances.’’ Slip. Op. at 3.
The Court specifically noted that I had
not considered Respondent’s experience
with the twelve patients whose charts
were seized in a search of her office, ‘‘or
with thousands of other patients.’’ Id. at
3.
The Court of Appeals did not cite to
any decision of either this Agency or
another court defining the term
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
‘‘positive experience.’’ Nor did the
Court offer any guidance as to the
meaning of this term, which is not to be
found in the Act.
For the purpose of resolving this
matter, I therefore assume—without
deciding—that the twelve patient charts
establish that Respondent’s prescribing
of controlled substance to these
individuals constitutes ‘‘positive
experience’’—whatever that means.3
3 Having carefully re-reviewed the charts, it
should be noted that some of the files suggest that
this is an assumption which is highly favorable to
Respondent. Under agency precedent, DEA’s
authority to suspend or revoke a registration is not
limited to those instances in which a practitioner
intentionally diverts. See Paul J. Caragine, Jr., 63 FR
51592 (1998). A practitioner who ignores the
warning signs that her patients are either personally
abusing or diverting controlled substances commits
‘‘acts inconsistent with the public interest,’’ 21
U.S.C. 824(a)(4), even if she is merely gullible or
¨
naıve. 63 FR at 51600. The twelve patient charts
cited by Respondent as evidence of her ‘‘positive
experience’’ included numerous instances in which
Respondent appears to have ignored warning signs
that the patient was either abusing or diverting
controlled substances.
For example, according to Respondent’s
evidence, ‘‘[o]n 10/05/99 a notation written in
[C.A.’s] progress notes states, ‘That the patient
called to say that a [D.M.] will call and tell you I’m
selling my drugs.’ It was later discovered that the
patient was in jail for violation of probation and
marijuana.’’ RX 21, at 2. In her testimony,
Respondent did not address what action she took
in response to this unusual phone call. See Tr. 433–
34. Moreover, the actual progress note for C.A.’s
October 5 visit is missing. Also missing are the
progress notes for numerous other office visits
which occurred (according to Respondent’s billing
records) on October 7 and 25, November 8 and
December 17.
On July 28, 1998, Respondent issued a
prescription for a drug (Soma) to C.C. RX 21, at 8.
That same day, Respondent’s office received a
phone call from a Walgreens pharmacy reporting
that two days earlier, C.C. had filled a prescription
for the same drug which was issued by a different
physician. Id. C.C. was thus clearly engaged in
doctor shopping.
Respondent saw C.C. three days later and yet
there is no indication in the progress note that she
even questioned him about the incident and
whether he was seeing other doctors. RX 90, at 29.
At this visit, Respondent issued him a prescription
for Dilaudid, a schedule II controlled substance. Id.
C.C. also demonstrated a consistent pattern of
coming in early. Respondent nonetheless continued
to prescribe controlled substances to him and did
not discharge him until approximately a year and
a half after the Walgreen’s incident. RX 90, at 1.
Respondent had previously discharged R.H.
based on a drug test which showed that he was
‘‘positive for drug dependency.’’ RX 92, at 22.
Respondent, however, accepted him back into her
practice. Id. It is acknowledged that upon his return
to her practice, Respondent counseled R.H. that if
he returned ‘‘to the same state of medications
taking’’ as ‘‘in the past, we will not be not be able
to continue.’’ Id. During the visit, Respondent
issued him a prescription for Dilaudid. Id.
Two days later, however, R.H. returned to
Respondent and complained that he could only get
part of his prescription filled and that he had come
back to get the balance of forty tablets. Respondent
‘‘continued his prescription for Dilaudid,’’ id. at 21,
even though the original prescription was still valid
under Federal law.
After a number of additional visits, in early
October, R.H. came in and represented that his
E:\FR\FM\06JAN1.SGM
06JAN1
Federal Register / Vol. 74, No. 3 / Tuesday, January 6, 2009 / Notices
mstockstill on PROD1PC66 with NOTICES
Moreover, although there is absolutely
no evidence in the record regarding the
propriety of Respondent’s prescribing of
controlled substances to the ‘‘thousands
of other patients’’ she has treated, for
the purpose of resolving this matter, I
again assume that her prescribings to
drugs had been ruined because he lived in a duplex
and the landlord’s hot water heater had failed and
flooded the whole house. Id. at 16. As Respondent
noted, R.H. had brought in ‘‘the whole bottle of
Dilaudid with water in it. I cannot tell if it is just
a powder or medicine.’’ Id. Respondent issued R.H.
a new prescription notwithstanding the likely
implausibility of his story and his past record as a
drug abuser. Id. Nor is there any evidence that she
attempted to verify whether the substance in the
bottle was in fact Dilaudid. In addition, R.H. made
numerous early visits, and on another occasion,
obtained prescriptions for Oxycontin and Percocet
after having claimed that he lost a prescription for
Dilaudid. Id. at 9.
While Respondent discharged J.B. on December 1,
1998, and represents that J.B. was discharged after
being arrested for photocopying prescriptions, see
RX 21, at 4; the online records of the Pinellas
County, Florida courts indicate that she had been
convicted on July 10, 1996, of attempting to obtain
a controlled substance by fraud, and that on June
9, 1998, a new complaint charging her with
obtaining or attempting to obtain a controlled
substance by fraud had been filed against her.
Moreover, J.B. made numerous early visits, a classic
behavior of drug seekers. See RX 93.
R.C. came in on October 21, 1998, nine days after
his initial visit with Respondent, and told her that
he had to come in early because he was going to
New York for four weeks and would run out of
medicine while he was out of town. RX 94, at 12.
Yet eight days later, R.C. was back to see
Respondent and seeking additional narcotics
because he was ‘‘going to Puerto Rico for some
relief work.’’ Id. at 11. However, during R.C.’s
initial visit, R.C. had stated that he was ‘‘on
disability’’ and was ‘‘not working.’’ Id. at 13.
Respondent nonetheless issued him new
prescriptions. Id. at 11. While it is unclear whether
R.C. told Respondent that he would be gone for six
weeks or six months, R.C. went back to see
Respondent on November 18 and 24, as well as on
December 1, 1998. Id. at 15.
On August 21, 1998, Respondent gave B.B. a
prescription for Dilaudid (and Soma) for pain in
various body parts and indicated that she would be
seen ‘‘next month for the followup.’’ RX 99, at 7.
On September 2 (eleven days later), B.B. returned
to Respondent and reported that ‘‘she is going to
Miami for about three to four weeks for her
deposition.’’ Id. at 6. Respondent ‘‘continued[d] her
prescriptions for Dilaudid and Soma.’’ Id. Twelve
days later, B.B. returned to Respondent. Id. at 5.
According to the progress note: B.B. ‘‘is going to
Miami for her case. She will be gone four to six
weeks. She came in early today because she does
not have enough medicine for four to six weeks. ‘‘
Id. Respondent issued B.B. additional prescriptions
for Dilaudid (and Soma) and indicated that she
would be seen again in a month. Id. Ten days later,
B.B. returned again to Respondent. Id. at 4.
According to the progress note, B.B. ‘‘came early
today because she will be evacuated from the Fort
Lauderdale area. No more court cases.’’ Id. B.B. also
told Respondent that the pharmacy had called and
told her that ‘‘they could not fill the prescription,
because it was unreadable,’’ (as if the pharmacy
would not have called Respondent to verify the
script) and that B.B. ‘‘could not get the prescription
back from the pharmacy, so she does not have any
medicine [because] she had to leave it in Fort
Lauderdale.’’ Id.
VerDate Nov<24>2008
16:52 Jan 05, 2009
Jkt 217001
these individuals constitutes ‘‘positive
experience.’’
Discussion
Section 304(a) of the Controlled
Substances Act (CSA) provides that a
registration to ‘‘dispense a controlled
substance* * * may be suspended or
revoked by the Attorney General upon
a finding that the registrant* * * has
committed such acts as would render
his registration under section 823 of this
title inconsistent with the public
interest as determined under such
section.’’ 21 U.S.C. § 824(a)(4) (emphasis
added). With respect to a practitioner,
the Act requires the consideration of the
following factors in making the public
interest determination:
(1) The recommendation of the appropriate
State licensing board or professional
disciplinary authority.
(2) The applicant’s experience in
dispensing* * * controlled substances.
(3) The applicant’s conviction record under
Federal or State laws relating to the
manufacture, distribution, or dispensing of
controlled substances.
(4) Compliance with applicable State,
Federal, or local laws relating to controlled
substances.
(5) Such other conduct which may threaten
the public health and safety.
Id. § 823(f).
[T]hese factors are * * * considered
in the disjunctive.’’ Robert A. Leslie,
M.D., 68 FR 15227, 15230 (2003). It is
well settled that I ‘‘may rely on any one
or a combination of factors, and may
give each factor the weight [I] deem[]
appropriate in determining whether a
registration should be revoked.’’ Id.;
Hoxie v. DEA, 419 F.3d 477, 482 (6th
Cir. 2005). Moreover, I am ‘‘not required
to make findings as to all of the factors.’’
See Hoxie, 419 F.3d at 482; see also
Morall v. DEA, 412 F.3d 165, 173–74
(D.C. Cir. 2005).59
As explained below, I adhere to my
initial findings regarding factors one
through four. As found in the original
Order, the State of Florida took no
action against Respondent’s state
medical license and Respondent has not
been convicted of an offense under
either Federal or State laws relating to
controlled substances. 71 FR at 52158–
59. DEA has long held, however, that a
State’s failure to take action against a
registrant’s medical license is not
dispositive in determining whether the
continuation of a registration is in the
public interest. See, e.g., Mortimer B.
Levin, 55 FR 8209, 8210 (1990) (holding
that practitioner’s reinstatement by state
board ‘‘is not dispositive’’; ‘‘DEA
maintains a separate oversight
responsibility with respect to the
handling of controlled substances and
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
461
has a statutory obligation to make its
independent determination as to
whether the granting of [a registration]
would be in the public interest’’). Nor is
the fact that a registrant/applicant has
not been convicted of a controlled
substance offense dispositive of whether
the continuation of her registration is in
the public interest. See also Edmund
Chein, 72 FR 6580, 6593 n.22 (2007).
Pursuant to the Court of Appeals’
judgment, I have re-considered the
additional evidence pertaining to
Respondent’s ‘‘positive experience.’’
Having done so, I again conclude that
Respondent violated Federal law and
regulations in issuing the prescriptions
to the undercover operatives. I also
conclude that Respondent violated
Federal law and regulations when she
pre-signed prescriptions (which she
gave to her nurse) and delegated to him
her authority to prescribe controlled
substances, even though he was not
registered to prescribe under Federal
law and could not lawfully prescribe
controlled substances under state law. I
therefore conclude that Respondent
committed acts inconsistent with the
public interest and which support the
suspension or revocation of her
registration. 21 U.S.C. 824(a)(4).
However, Respondent has now
credibly acknowledged that her
prescribing to the undercover operatives
and her pre-signing of the prescriptions
was improper. She has also credibly
stated that she has not engaged in such
conduct since the events at issue here
and has promised that she will not do
so in the future.4 I therefore further
conclude that Respondent has accepted
responsibility for her misconduct and
can be entrusted with a new registration
subject to the condition agreed to by the
parties.
Factor Two and Four—Respondent’s
Experience in Dispensing Controlled
Substances and Record of Compliance
With Applicable Controlled Substance
Laws
Under a longstanding DEA regulation,
a prescription for a controlled substance
is not ‘‘effective’’ unless it is ‘‘issued for
a legitimate medical purpose by an
individual practitioner acting in the
usual course of his professional
practice.’’ 21 CFR 1306.04(a). Under the
CSA, it is fundamental that a
practitioner must establish a bonafide
doctor-patient relationship in order to
act ‘‘in the usual course of * * *
professional practice’’ and to issue a
prescription for a ‘‘legitimate medical
4 In the original Order, I acknowledged that
Respondent had undertaken substantial measures to
reform her practice. 71 FR at 52156 & 52159.
E:\FR\FM\06JAN1.SGM
06JAN1
462
Federal Register / Vol. 74, No. 3 / Tuesday, January 6, 2009 / Notices
mstockstill on PROD1PC66 with NOTICES
purpose.’’ See United States v. Moore,
423 U.S. 122 (1975); see also 21 CFR
1306.04(a) (‘‘an order purporting to be a
prescription issued not in the usual
course of professional treatment * * *
is not a prescription within the meaning
and intent of [21 U.S.C. 829] and * * *
the person issuing it, shall be subject to
the penalties provided for violations of
the provisions of law related to
controlled substances’’).
As the Supreme Court recently
explained, ‘‘the prescription
requirement* * * ensures patients use
controlled substances under the
supervision of a doctor so as to prevent
addiction and recreational abuse. As a
corollary, [it] also bars doctors from
peddling to patients who crave the
drugs for those prohibited uses.’’
Gonzales v. Oregon, 546 U.S. 243, 274
(2006) (citing Moore, 423 U.S. 122, 135
& 143 (1975)).
In this matter, the Government’s
presentation largely focused on two
allegations: (1) That Respondent lacked
a legitimate purpose in issuing the
prescriptions to the undercover
operatives, and (2) that Respondent presigned blank prescriptions which she
gave to her nurse and allowed him to
prescribe drugs even though the nurse
was not authorized under either Federal
or State law to prescribe controlled
substances.
Whether this conduct is evaluated
under factor two—the experience factor,
or factor four—the compliance factor, or
both, is of no legal consequence. In
establishing its prima facie case, the
fundamental question is whether
Respondent ‘‘has committed such acts
as would render [her] registration * * *
inconsistent with the public interest.’’
21 U.S.C. 824(a)(4). As explained above,
this Agency has long held—and other
courts of appeals have at least implicitly
recognized—that findings under a single
factor are sufficient to support the
revocation of a registration. See Hoxie,
419 F.3d at 482; Morall, 412 F.3d at
173–74.
In short, this is not a contest in which
score is kept; the Agency is not required
to mechanically count up the factors
and determine how many favor the
Government and how many favor the
registrant. Rather, it is an inquiry which
focuses on protecting the public
interest; what matters is the seriousness
of the registrant’s misconduct.5
5 The
Court of Appeals interpreted my prior
decision as ‘‘[b]alancing the factors and according
‘dispositive’ weight to factor five.’’ Slip. Op. at 5.
This suggests that the factors that favored
Respondent’s continued registration (factors one
and three) were in equipoise with the factors that
did not support her continued registration. They
were not. As explained above, even if Respondent’s
VerDate Nov<24>2008
16:52 Jan 05, 2009
Jkt 217001
As previously found, on three
separate occasions, undercover
operatives went to Respondent seeking
prescriptions for controlled substances.
Each of the operatives stated that they
were not in pain and that they had been
obtaining controlled substances from
such non-legitimate sources as a
‘‘girlfriend’’ (first visitor), ‘‘a friend’’
(second visitor) and ‘‘a family member
who has a prescription’’ (third visitor).
71 FR at 52150, 52152, and 52154.
Respondent did not perform a physical
examination on any of the three
operatives, even though she
acknowledged that performing a
physical exam ‘‘is the standard of
practice’’ and ‘‘our Rule No.1.’’ Id. at
52154. Moreover, she falsified each
operative’s medical record to indicate
that she had performed a physical exam.
Id. at 52150 (first visitor), 52153 (second
visitor), & 52154 (third visitor).
Most significantly, Respondent’s
statements as recorded on the wire
amply demonstrate that she knew that
the operatives were seeking the drugs
not for the purpose of treating a
legitimate medical condition, but to
abuse them. See 71 FR at 52150 (stating
to first visitor: ‘‘this is a shame * * *
that you have to take the medicine for
the habit,’’ ‘‘you can tell me that you
want to come out of drugs’’); id. at
52152 (asking second visitor: ‘‘you don’t
have pain but you are taking vicodin?’’
and do you ‘‘want to go to substance
abuse program or do you want to be
maintained on the vicodin?’’); id.
(stating to second visitor: ‘‘maybe I’m
sympathetic to the people that allow
themselves to slip into drugs’’); id. at
52154 (during visit of third operative,
when asked by her nurse, ‘‘what’s the
source of the pain?’’, replying: ‘‘I guess
he feels no pain, he just feels better.’’);
id. (stating to third visitor: ‘‘we will not
be supporting just a drug habit’’).
In various briefs, Respondent
maintains that at the time of the search,
she had already discharged 6 of the 12
patients ‘‘for various reasons including
non-compliance with the Prescription
Pain Medication Agreement, criminal
acts or arrest.’’ Resp. Exceptions to ALJ
Dec. at 42. She contends that this is
exculpatory evidence of her intent to
not improperly prescribe drugs. Id.
As found above, it is true that five of
the patients whose files were seized had
conduct had been discussed under a single factor,
the conduct still would have established a prima
facie case that her continued registration was
inconsistent with the public interest. Factor five
was dispositive because once the Government
established a prima facie case, the burden shifted
to the Respondent to demonstrate that her
continued registration was consistent with the
public interest.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
been discharged before the search was
conducted. Yet even assuming that this
evidence is relevant as to Respondent’s
intent with respect to her prescribings to
the undercover operatives, it is not more
probative of her intent during the visits
than the evidence as to what actually
occurred during those visits. Indeed,
even if the operatives’ initial statements
to Respondent were ambiguous as to
why they were seeking the drugs,
Respondent did not perform a physical
exam on any of the operatives (yet
falsified the records to indicate that she
had done so) and her subsequent
statements during the visits made clear
that she had resolved any doubt as to
why the operatives were seeking the
drugs. In short, the evidence is clear that
Respondent issued prescriptions to each
of the undercover operatives knowing
that they were seeking controlled
substances for the purpose of abusing
them and not to treat a legitimate
medical condition.6 I thus conclude that
Respondent lacked a legitimate medical
purpose and thus violated Federal law
and DEA regulations when she issued
the prescriptions to the undercover
operatives.
In her exceptions, Respondent argued
that ‘‘her treatment of each of the
[twelve] patients [whose files were
seized] was proper,’’ and that the
‘‘Government presented no evidence
suggesting that the treatment of those
twelve patients was anything but
proper.’’ Id. Respondent also contends
that she ‘‘properly treated thousands of
patients for chronic pain,’’ and that ‘‘the
Government was unable to present any
evidence that there was any problem
with any non-undercover patient.’’ Id. at
64. Relatedly, the Court of Appeals has
instructed that the experience factor be
reconsidered ‘‘pay[ing] particular
attention to the entire corpus of
Petitioner’s record in dispensing
controlled substances.’’ Slip Op. at 3.
As stated above, for the purpose of
resolving this matter, I have assumed
that Respondent’s prescribings of
6 I acknowledge that some courts allow a
defendant in criminal matters to admit evidence of
her ‘‘prior good acts’’ to prove she lacked criminal
intent. See United States v. Thomas, 134 F.3d 975,
979 (9th Cir. 1998); United States v. Garvin, 565
F.2d 519, 521–22 (8th Cir. 1977). Putting aside that
this is not a criminal proceeding and the Federal
Rules of Evidence do not apply, Respondent made
no showing that the factual circumstances
surrounding her discharging of these patients were
similar to the circumstances involved in the
undercover visits. Indeed, in four of the five
instances, the patients had been caught by others
engaging in problematic behavior such as criminal
acts present altering or photocopying prescriptions,
(K.L. and J.B.), that the patient was receiving drugs
from another clinic (J.L.), or a report from the
patient’s mother that he was abusing drugs (R.S.).
RX 21, at 4, 23, 24 and 34.
E:\FR\FM\06JAN1.SGM
06JAN1
mstockstill on PROD1PC66 with NOTICES
Federal Register / Vol. 74, No. 3 / Tuesday, January 6, 2009 / Notices
controlled substances to every other
person she has treated constitute
‘‘positive experience.’’ Her prescribings
to thousands of other patients do not,
however, render her prescribings to the
undercover officers any less unlawful,
or any less acts which ‘‘are inconsistent
with the public interest.’’ 21 U.S.C.
§ 823(f).
In enacting the CSA, Congress
recognized that ‘‘[m]any of the drugs
included within [the CSA] have a useful
and legitimate medical purpose and are
necessary to maintain the health and
general welfare of the American
people.’’ 21 U.S.C. 801(1). Moreover,
under the CSA, a practitioner is not
entitled to a registration unless she ‘‘is
authorized to dispense * * * controlled
substances under the laws of the State
in which [she] practices.’’ 21 U.S.C.
823(f). Because under law, registration
is limited to those who have authority
to dispense controlled substances in the
course of professional practice, and
patients with legitimate medical
conditions routinely seek treatment
from licensed medical professionals,
every registrant can undoubtedly point
to an extensive body of legitimate
prescribing over the course of her
professional career.
Thus, in past cases, this Agency has
given no more than nominal weight to
a practitioner’s evidence that he has
dispensed controlled substances to
thousands of patients in circumstances
which did not involve diversion. See,
e.g., Caragine, 63 FR at 51599 (‘‘[T]he
Government does not dispute that
during Respondent’s 20 years in
practice he has seen over 15,000
patients. At issue in this proceeding is
Respondent’s controlled substance
prescribing to 18 patients.’’); id. at
51600 (‘‘[E]ven though the patients at
issue are only a small portion of
Respondent’s patient population, his
prescribing of controlled substances to
these individuals raises serious
concerns regarding [his] ability to
responsibly handle controlled
substances in the future.’’).
While in Caragine, my predecessor
did consider ‘‘that the patients at issue
ma[de] up a very small percentage of
Respondent’s total patient population,’’
he also noted—in contrast to the
prescribings at issue here—‘‘that [those]
patients had legitimate medical
problems that warranted some form of
treatment.’’ Id. at 51601. Moreover, in
contrast to this case, in Caragine, there
was no evidence that the practitioner
had intentionally diverted. Id. See also
Medicine Shoppe—Jonesborough, 73 FR
364, 386 & n.56 (2008) (noting that
pharmacy ‘‘had 17,000 patients,’’ but
that ‘‘[n]o amount of legitimate
VerDate Nov<24>2008
16:52 Jan 05, 2009
Jkt 217001
dispensings can render * * * flagrant
violations [acts which are] ‘consistent
with the public interest.’ ’’), aff’d,
Medicine Shoppe-Jonesborough v. DEA,
slip. op. at 11 (6th Cir. Nov. 13, 2008).
Indeed, DEA has revoked other
practitioners’ registrations for
committing as few as two acts of
diversion. See Alan H. Olefsky, 57 FR
928, 928–29 (1992) (revoking
registration based on physician’s
presentation of two fraudulent
prescriptions to pharmacy and noting
that the respondent ‘‘refuses to accept
responsibility for his actions and does
not even acknowledge the criminality of
his behavior’’). See also Sokoloff v.
Saxbe, 501 F.2d 571, 576 (2d Cir. 1974)
(upholding revocation of practitioner’s
registration based on nolo contendere
plea to three counts of unlawful
distribution).
Accordingly, evidence that a
practitioner has treated thousands of
patients does not negate a prima facie
showing that the practitioner has
committed acts inconsistent with the
public interest. While such evidence
may be of some weight in assessing
whether a practitioner has credibly
shown that she has reformed her
practices, where a practitioner commits
intentional acts of diversion and insists
she did nothing wrong, such evidence is
entitled to no weight. As I held in the
original decision, I again conclude that
Respondent’s dispensings to the
undercover officers and her pre-signing
of prescriptions and unlawful
delegation of her prescribing authority
to her nurse, establish a prima facie case
that her continued registration is
‘‘inconsistent with the public interest.’’
Under longstanding Agency
precedent, where, as here, ‘‘the
Government has proved that a registrant
has committed acts inconsistent with
the public interest, a registrant must
‘present sufficient mitigating evidence
to assure the Administrator that [he] can
be entrusted with the responsibility
carried by such a registration.’ ’’
Medicine Shoppe, 73 FR at 387 (quoting
Samuel S. Jackson, 72 FR 23848, 23853
(2007) (quoting Leo R. Miller, 53 FR
21931, 21932 (1988))). ‘‘Moreover,
because ‘past performance is the best
predictor of future performance,’ ALRA
Labs, Inc. v. DEA, 54 F.3d 450, 452 (7th
Cir. 1995), [DEA] has repeatedly held
that where a registrant has committed
acts inconsistent with the public
interest, the registrant must accept
responsibility for [her] actions and
demonstrate that [she] will not engage
in future misconduct.’’ Medicine
Shoppe, 73 FR at 387; see also Jackson,
72 FR at 23853; John H. Kennedy, 71 FR
35705, 35709 (2006); Prince George
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
463
Daniels, 60 FR 62884, 62887 (1995). See
also Hoxie v. DEA, 419 F.3d at 483
(‘‘admitting fault’’ is ‘‘properly
consider[ed]’’ by DEA to be an
‘‘important factor[]’’ in the public
interest determination).
In this matter, I previously revoked
Respondent’s registration because
notwithstanding all of the measures she
had undertaken to reform her practice,
she was the person with the prescribing
authority and had refused to
acknowledge her responsibility under
the law. 71 FR at 52159. Had this case
come back to me with the same
evidentiary record as before, I would
again revoke her registration.
Respondent, however, has now
acknowledged wrongdoing with respect
to both her prescribings to the
undercover operatives, as well as her
pre-signing of prescriptions and
delegation of her prescribing authority
to her nurse, who could not legally
prescribe a controlled substance under
either the CSA or Florida Law.
Moreover, Respondent’s registration was
effectively suspended for a period of
approximately one year. I therefore
conclude that the parties’ proposed
resolution of this matter is in the public
interest.
*
*
*
*
*
The diversion of controlled
substances has become an increasingly
grave threat to this nation’s public
health and safety. According to The
National Center on Addiction and
Substance Abuse (CASA), ‘‘[t]he number
of people who admit abusing controlled
prescription drugs increased from 7.8
million in 1992 to 15.1 million in
2003.’’ National Center on Addiction
and Substance Abuse, Under the
Counter: The Diversion and Abuse of
Controlled Prescription Drugs in the
U.S. 3 (2005). Moreover,
‘‘[a]pproximately six percent of the U.S.
population (15.1 million people)
admitted abusing controlled
prescription drugs in 2003, 23 percent
more than the combined number
abusing cocaine (5.9 million),
hallucinogens (4.0 million), inhalants
(2.1 million) and heroin (328,000).’’ Id.
Relatedly, ‘‘[b]etween 1992 and 2003,
there has been a * * * 140.5 percent
increase in the self-reported abuse of
prescription opioids,’’ and in the same
period, the ‘‘abuse of controlled
prescription drugs has been growing at
a rate twice that of marijuana abuse, five
times greater than cocaine abuse and 60
times greater than heroin abuse.’’ Id. at
4.7
7 According to a recent newspaper article,
‘‘[p]rescription painkiller and anti-anxiety drugs
E:\FR\FM\06JAN1.SGM
Continued
06JAN1
464
Federal Register / Vol. 74, No. 3 / Tuesday, January 6, 2009 / Notices
mstockstill on PROD1PC66 with NOTICES
While some isolated decisions of this
Agency may suggest that a practitioner
who committed only a few acts of
diversion was entitled to regain his
registration even without having to
accept responsibility for his
misconduct, see Anant N. Mauskar, 63
FR 13687, 13689 (1998), the great
weight of the Agency’s decisions are to
the contrary. In any event, the increase
in the abuse of prescription controlled
substances calls for a clarification of this
Agency’s policy. Because of the grave
and increasing harm to public health
and safety caused by the diversion of
prescription controlled substances, even
where the Agency’s proof establishes
that a practitioner has committed only
a few acts of diversion, this Agency will
not grant or continue the practitioner’s
registration unless he accepts
responsibility for his misconduct.8 Put
another way, even where the
Government proves only a few instances
of illegal prescribing in the ‘‘entire
corpus’’ of a practitioner’s experience,
the Government has nonetheless made
out a prima facie case and thus shifted
the burden to the registrant to show why
he should be entrusted with a new
registration.9
I have abided by the judgment of the
Court of Appeals in this matter.
However, some may interpret the
Court’s decision as suggesting that ‘‘the
entire corpus’’ of a practitioner’s record
in dispensing controlled substances can
outweigh a practitioner’s intentional
acts of diversion where DEA only
proves that a few acts of diversion have
occurred.
The Court’s decision was not
published and the Court did not instruct
the Agency as to how much weight the
entire corpus should be given. Nor did
the Court explain whether ‘‘the entire
corpus’’ should be considered as part of
the Government’s prima facie case, or as
part of the registrant’s rebuttal of the
Government’s case.
now kill about 500 people a year in the Tampa Bay
area, triple the number killed by illegal drugs such
as cocaine and heroin.’’ Chris Tisch & Abbie
Vansickle, Deadly Combinations, St. Petersburg
Times (Feb. 17, 2008), at 1. This article further
noted that while at the time of publication, the
figures for the year 2007 were not complete, ‘‘the
area is on pace for about 550 deaths,’’ and that
‘‘prescription drug overdoses are likely to overtake
car crashes as the leading cause of accidental
death.’’ Id. In contrast, in 2006, 433 people died of
prescription drug overdoses, and in 2005, 339 died.
Id. According to the Circuit Judge who runs the
Pinellas County drug court, ‘‘This has become an
epidemic.’’ Id.
8 Depending upon the facts and circumstances, a
registrant/applicant may also be required to show
what corrective measures he/she has instituted to
prevent such acts from re-occurring.
9 To the extent Mauskar, or any other decision of
this Agency suggests otherwise, it is overruled.
VerDate Nov<24>2008
16:52 Jan 05, 2009
Jkt 217001
DEA therefore does not interpret the
decision as altering the manner in
which similar arguments have been
dealt with in prior cases. While such
evidence may have some probative
value, it does not negate a prima facie
showing that a registrant/applicant has
committed acts that are inconsistent
with the public interest. It may,
however, be entitled to some weight in
assessing whether a registrant/applicant
has demonstrated that she can be
entrusted with a new registration where
the Government’s proof is limited to
relatively few acts and a registrant puts
forward credible evidence that she has
accepted responsibility for her
misconduct.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) & 824(a), as well as
28 CFR 0.100(b) & 0.104, I hereby order
that the DEA Certificate of Registration
issued to Jayam Krishna-Iyer, M.D., be,
and it hereby is, suspended. I further
order that the suspension shall be
retroactive and limited to the period
beginning on October 2, 2006, and
ending on October 2, 2007, when her
registration was restored pursuant to the
judgment of the Court of Appeals. I
further order that the application of
Jayam Krishna-Iyer, M.D., for renewal of
her registration be, and it hereby is,
granted subject to the condition that she
file monthly reports with the Special
Agent in Charge (or his designee) of the
Miami Field Division for a period of one
year. The reports shall list all controlled
substances prescribed by the patient’s
name, the date, the name of the drug, its
strength, the quantity prescribed, and
the number of refills authorized. The
reports shall be due no later than the
tenth day of the subsequent month and
shall list all patients in alphabetical
order.10 Failure to comply with the
terms of this Order shall be grounds for
the suspension or revocation of
Respondent’s registration. This Order is
effective immediately.
Dated: December 19, 2008.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E8–31412 Filed 1–5–09; 8:45 am]
BILLING CODE 4410–09–P
10 If a patient received multiple prescriptions, all
prescriptions issued to the patient within the
calendar month shall be listed before the
prescriptions for the next patient are reported.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
DEPARTMENT OF LABOR
Bureau of Labor Statistics
Proposed Collection, Comment
Request
ACTION:
Notice.
SUMMARY: The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a pre-clearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information, in accordance with the
Paperwork Reduction Act of 1995
(PRA95) [44 U.S.C. 3506(c)(2)(A)]. This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. The Bureau of Labor
Statistics (BLS) is soliciting comments
on the proposed extension of the Labor
Market Information (LMI) Cooperative
Agreement application package. A copy
of the proposed information collection
request (ICR) can be obtained by
contacting the individual listed below
in the Addresses section of this notice.
DATES: Written comments must be
submitted to the office listed in the
ADDRESSES section of this notice on or
before March 9, 2009.
ADDRESSES: Send comments to Carol
Rowan, BLS Clearance Officer, Division
of Management Systems, Bureau of
Labor Statistics, Room 4080, 2
Massachusetts Avenue, NE.,
Washington, DC 20212, telephone
number 202–691–7099. (This is not a
toll free number.)
FOR FURTHER INFORMATION CONTACT:
Carol Rowan, BLS Clearance Officer,
telephone number 202–691–7099. (See
ADDRESSES section.)
SUPPLEMENTARY INFORMATION:
I. Background
The BLS enters into Cooperative
Agreements with State Workforce
Agencies (SWAs) annually to provide
financial assistance to the SWAs for the
production and operation of the
following LMI statistical programs:
Current Employment Statistics, Local
Area Unemployment Statistics,
Occupational Employment Statistics,
Quarterly Census of Employment and
Wages, and Mass Layoff Statistics. The
Cooperative Agreement provides the
basis for managing the administrative
and financial aspects of these programs.
E:\FR\FM\06JAN1.SGM
06JAN1
Agencies
[Federal Register Volume 74, Number 3 (Tuesday, January 6, 2009)]
[Notices]
[Pages 459-464]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-31412]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 03-8]
Jayam Krishna-Iyer, M.D.; Suspension of Registration; Granting of
Renewal Application Subject to Condition
On September 1, 2006, I, the Deputy Administrator of the Drug
Enforcement Administration, ordered that the DEA Certificate of
Registration issued to Jayam Krishna-Iyer, M.D. (Respondent), of
Clearwater, Florida, be revoked. Jayam Krishna-Iyer, M.D., 71 FR 52148,
52159 (2006). The Order also denied Respondent's pending application
for renewal of her registration.
As grounds for the Order, I noted that Respondent had issued
prescriptions for controlled substances to three separate undercover
operatives notwithstanding that each of the operatives had indicated
that he was not in pain, and had told Respondent that he was obtaining
controlled substances from non-legitimate sources such as friends. Id.
at 52158. I further noted that Respondent had failed to conduct a
physical exam on each of the undercover operatives and had falsified
each operative's medical record to indicate that she had done an exam.
Id. I also noted that Respondent had made statements during each
operative's visit indicating that she knew that the operative was
seeking the drugs to abuse them and not to treat pain. Id. Finally, I
noted that Respondent had pre-signed prescriptions and given them to a
registered nurse in her employ, and that she allowed the nurse to issue
prescriptions to one of the operatives even though she did not attend
to the operative during the visit and the nurse lacked authority under
both Federal law and Florida law to prescribe controlled substances.
Id.
In the decision, I noted that Respondent had undertaken substantial
measures to reform her practice including hiring a private
investigation firm to review patient records to determine which
patients were likely substance abusers and should be discharged from
her practice; the firm also developed procedures for recognizing drug
abusers, doctor shoppers, prescription fraud, patients with a drug-
related criminal history, and dealing with claims of lost and stolen
medications. Id. at 52156. I also noted that the firm had conducted
extensive criminal history checks on Respondent's patients and that she
had discharged a large of number of patients. Id.
While I recognized the substantial measures that Respondent had
undertaken to reform her practice, I adopted the ALJ's finding that
Respondent failed to accept responsibility for her misconduct based on
her testimony that she did not intentionally or knowingly distribute a
controlled substance to the undercover operatives because she knew the
drugs would not be sold on the street. Id. at 52159. As I explained in
the Order, ``[i]t is no less a violation that the `patient' will
personally use the drug rather than sell it on the street.'' Id. I
further concluded that because Respondent had ``refuse[d] to
acknowledge her responsibilities under the law,'' the reforms she had
undertaken would ``still not adequately protect public health and
safety,'' and that this finding was dispositive as to whether her
continued registration would be consistent with the public interest.
Id.
Thereafter, Respondent filed a petition for review in the U.S.
Court of Appeals for the Eleventh Circuit. On September 25, 2007,
following briefing and oral argument, the Court vacated the Agency's
Order in an unpublished opinion. Krishna-Iyer v. DEA, No. 06-15034
(11th Cir. 2007), Slip Op. at 3. The Court declared:
In considering Petitioner's experience in dispensing controlled
substances under factor 2, the DEA identified only four visits by
three undercover `patient,' who were all attempting to make a case
against her. The DEA failed to consider Petitioner's experience with
twelve patients whose medical charts were seized by the DEA, or with
thousands of other patients. In short, the DEA did not consider any
of Petitioner's positive experience in dispensing controlled
substances. This is an arbitrary and unfair analysis of Petitioner's
experience.
Id. The Court therefore vacated the Order and remanded the case for
reconsideration, directing that ``DEA should pay particular attention
to the entire corpus of Petitioner's record in dispensing controlled
substances, not only the experience of [the] undercover officer.'' Id.
The Court further ordered that ``[t]he five factors should * * * be re-
balanced.'' Id.
On September 15, 2008, the Parties submitted a joint motion which
proposed a resolution of the matter. More specifically, the Parties
propose that I ``issue a new final Order consistent with the direction
of the * * * Court of Appeals.'' Joint Motion at 2. The Parties also
request that were I to find that ``revocation or suspension is still an
appropriate outcome,'' that the sanction be limited ``to suspension of
[her] registration for the time'' that the Final Order remained in
effect. The Parties also requested that I direct that Respondent's
pending renewal application be acted upon expeditiously. Finally, the
Parties represented that if I concurred with their proposed resolution,
they would enter into a Memorandum of Agreement (MOA) under which
Respondent's registration will be renewed subject to the condition that
for a one year period, she file monthly reports with the Agency's Miami
Field Division providing information regarding her prescribing of
controlled substances.
Attached to the Joint Motion was Respondent's statement. In her
[[Page 460]]
statement, Respondent: (1) ``Acknowledge[d] wrongdoing for failing to
conduct physical examinations of the three undercover patients in this
case''; (2) ``acknowledge[d] wrongdoing for improperly indicating on
the charts of the undercover patients that she had conducted a physical
examination of'' them; and (3) ``acknowledge[d] that she had presigned
various prescriptions and * * * understands that this was improper.''
Respondent's Statement at 1. Respondent also apologized for her conduct
with respect to each of the above actions and promises that she will
not engage in similar conduct in the future.\1\ Id.
Respondent also stated that she has reviewed the Agency's earlier
decision, that she ``has reexamined her conduct with respect to the
three undercover patients in light of the [Agency's] decision and has
re-evaluated the transcripts of the visits of the undercover patients
in light of the * * * decision.'' Id. Respondent further stated that
``she regret[ed] that she prescribed the medications which she
prescribed to the undercover patients'' and ``apologized * * * for her
conduct.'' Id. Respondent also promised that ``such conduct has not
occurred since [the undercover visits] and will not occur again.'' \2\
---------------------------------------------------------------------------
\1\ With respect to the pre-signing of prescriptions, Respondent
stated that ``she had not engaged in such conduct since being
advised by the DEA that such conduct was improper and promises that
she will not in the future.'' Respondent's Statement at 1.
\2\ Respondent also expressed regret and apologized for doctor-
shopping and inappropriate diversion of drugs at her clinic.
Respondent's Statement at 2. I acknowledge (as I did in the original
decision) the extensive efforts Respondent has undertaken to prevent
the diversion and abuse of drugs by her patients. I also acknowledge
Respondent's successful completion of the one-year period of
monitoring of her practice.
---------------------------------------------------------------------------
Findings
I incorporate by reference my findings of fact contained in the
original order and found at pages 71 FR at 52149-56. As previously
found, and as Respondent acknowledges, she issued controlled substance
prescriptions to three undercover operatives without performing
physical examinations on them and falsified medical records to indicate
that she had performed a physical exam. Moreover, Respondent prescribed
controlled substances to the undercover operatives even though each of
them represented that they were not in pain and were obtaining the
drugs from non-legitimate sources such as friends or family members.
Moreover, during each of the visits, Respondent made statements that
indicated that she knew the patients were seeking the drugs to abuse
them and not to treat a legitimate medical condition. See id. at 52150
(Respondent stating during first undercover visit: ``Lorcet 10/650.
See, this is a shame then that you have to take the medicine for the
habit.''); id. at 52152 (after acknowledging that second undercover
operative had told her that he was taking four to five Vicodin a day
even though he did not have pain, and was taking them because he
``functioned better,'' Respondent asked him if he ``want[ed] to go to
substance abuse program or * * * be maintained on the vicodin?''); id.
(stating to second undercover operative ``maybe I'm sympathetic to the
people that allow themselves to slip into drugs''); id. at 52154
(during visit of third operative, when asked by her nurse, ``what's the
source of the pain?,'' replying: ``I guess he feels no pain, he just
feels better.''); id. (stating to third visitor: ``we will not be
supporting just a drug habit'').
Having reviewed--for a second time--the twelve patient files that
were seized during the January 26, 2000 search, I further find that
Respondent discharged five of these patients prior to the search. More
specifically, I find that: (1) Respondent discharged K.L. on February
2, 1998, upon her office's being notified that she had altered a
prescription; (2) Respondent discharged R.H. on February 11, 1999, for
various reasons including his having claimed that his drugs had been
lost or stolen, and his coming in early to obtain new prescriptions
claiming that he was going out of town; (3) Respondent discharged J.B.
on December 1, 1998, after her office was notified that she had been
arrested for photocopying prescriptions and presenting them for filling
to multiple pharmacies; (4) Respondent discharged R.S. on December 2,
1999, after being called by his mother who reported that he was abusing
his medications; and (5) Respondent discharged J.L. on January 24,
2000, after an anonymous caller reported to Respondent's office that he
was simultaneously receiving treatment at a methadone clinic. See RX
21, at 4, 17, 23, 24 & 34
As stated above, the Court of Appeals vacated the original Order on
the ground that it failed to consider ``any of'' what it termed
[Respondent's] ``positive experience in dispensing controlled
substances.'' Slip. Op. at 3. The Court specifically noted that I had
not considered Respondent's experience with the twelve patients whose
charts were seized in a search of her office, ``or with thousands of
other patients.'' Id. at 3.
The Court of Appeals did not cite to any decision of either this
Agency or another court defining the term ``positive experience.'' Nor
did the Court offer any guidance as to the meaning of this term, which
is not to be found in the Act.
For the purpose of resolving this matter, I therefore assume--
without deciding--that the twelve patient charts establish that
Respondent's prescribing of controlled substance to these individuals
constitutes ``positive experience''--whatever that means.\3\
[[Page 461]]
Moreover, although there is absolutely no evidence in the record
regarding the propriety of Respondent's prescribing of controlled
substances to the ``thousands of other patients'' she has treated, for
the purpose of resolving this matter, I again assume that her
prescribings to these individuals constitutes ``positive experience.''
---------------------------------------------------------------------------
\3\ Having carefully re-reviewed the charts, it should be noted
that some of the files suggest that this is an assumption which is
highly favorable to Respondent. Under agency precedent, DEA's
authority to suspend or revoke a registration is not limited to
those instances in which a practitioner intentionally diverts. See
Paul J. Caragine, Jr., 63 FR 51592 (1998). A practitioner who
ignores the warning signs that her patients are either personally
abusing or diverting controlled substances commits ``acts
inconsistent with the public interest,'' 21 U.S.C. 824(a)(4), even
if she is merely gullible or na[iuml]ve. 63 FR at 51600. The twelve
patient charts cited by Respondent as evidence of her ``positive
experience'' included numerous instances in which Respondent appears
to have ignored warning signs that the patient was either abusing or
diverting controlled substances.
For example, according to Respondent's evidence, ``[o]n 10/05/99
a notation written in [C.A.'s] progress notes states, `That the
patient called to say that a [D.M.] will call and tell you I'm
selling my drugs.' It was later discovered that the patient was in
jail for violation of probation and marijuana.'' RX 21, at 2. In her
testimony, Respondent did not address what action she took in
response to this unusual phone call. See Tr. 433-34. Moreover, the
actual progress note for C.A.'s October 5 visit is missing. Also
missing are the progress notes for numerous other office visits
which occurred (according to Respondent's billing records) on
October 7 and 25, November 8 and December 17.
On July 28, 1998, Respondent issued a prescription for a drug
(Soma) to C.C. RX 21, at 8. That same day, Respondent's office
received a phone call from a Walgreens pharmacy reporting that two
days earlier, C.C. had filled a prescription for the same drug which
was issued by a different physician. Id. C.C. was thus clearly
engaged in doctor shopping.
Respondent saw C.C. three days later and yet there is no
indication in the progress note that she even questioned him about
the incident and whether he was seeing other doctors. RX 90, at 29.
At this visit, Respondent issued him a prescription for Dilaudid, a
schedule II controlled substance. Id. C.C. also demonstrated a
consistent pattern of coming in early. Respondent nonetheless
continued to prescribe controlled substances to him and did not
discharge him until approximately a year and a half after the
Walgreen's incident. RX 90, at 1.
Respondent had previously discharged R.H. based on a drug test
which showed that he was ``positive for drug dependency.'' RX 92, at
22. Respondent, however, accepted him back into her practice. Id. It
is acknowledged that upon his return to her practice, Respondent
counseled R.H. that if he returned ``to the same state of
medications taking'' as ``in the past, we will not be not be able to
continue.'' Id. During the visit, Respondent issued him a
prescription for Dilaudid. Id.
Two days later, however, R.H. returned to Respondent and
complained that he could only get part of his prescription filled
and that he had come back to get the balance of forty tablets.
Respondent ``continued his prescription for Dilaudid,'' id. at 21,
even though the original prescription was still valid under Federal
law.
After a number of additional visits, in early October, R.H. came
in and represented that his drugs had been ruined because he lived
in a duplex and the landlord's hot water heater had failed and
flooded the whole house. Id. at 16. As Respondent noted, R.H. had
brought in ``the whole bottle of Dilaudid with water in it. I cannot
tell if it is just a powder or medicine.'' Id. Respondent issued
R.H. a new prescription notwithstanding the likely implausibility of
his story and his past record as a drug abuser. Id. Nor is there any
evidence that she attempted to verify whether the substance in the
bottle was in fact Dilaudid. In addition, R.H. made numerous early
visits, and on another occasion, obtained prescriptions for
Oxycontin and Percocet after having claimed that he lost a
prescription for Dilaudid. Id. at 9.
While Respondent discharged J.B. on December 1, 1998, and
represents that J.B. was discharged after being arrested for
photocopying prescriptions, see RX 21, at 4; the online records of
the Pinellas County, Florida courts indicate that she had been
convicted on July 10, 1996, of attempting to obtain a controlled
substance by fraud, and that on June 9, 1998, a new complaint
charging her with obtaining or attempting to obtain a controlled
substance by fraud had been filed against her. Moreover, J.B. made
numerous early visits, a classic behavior of drug seekers. See RX
93.
R.C. came in on October 21, 1998, nine days after his initial
visit with Respondent, and told her that he had to come in early
because he was going to New York for four weeks and would run out of
medicine while he was out of town. RX 94, at 12. Yet eight days
later, R.C. was back to see Respondent and seeking additional
narcotics because he was ``going to Puerto Rico for some relief
work.'' Id. at 11. However, during R.C.'s initial visit, R.C. had
stated that he was ``on disability'' and was ``not working.'' Id. at
13. Respondent nonetheless issued him new prescriptions. Id. at 11.
While it is unclear whether R.C. told Respondent that he would be
gone for six weeks or six months, R.C. went back to see Respondent
on November 18 and 24, as well as on December 1, 1998. Id. at 15.
On August 21, 1998, Respondent gave B.B. a prescription for
Dilaudid (and Soma) for pain in various body parts and indicated
that she would be seen ``next month for the followup.'' RX 99, at 7.
On September 2 (eleven days later), B.B. returned to Respondent and
reported that ``she is going to Miami for about three to four weeks
for her deposition.'' Id. at 6. Respondent ``continued[d] her
prescriptions for Dilaudid and Soma.'' Id. Twelve days later, B.B.
returned to Respondent. Id. at 5. According to the progress note:
B.B. ``is going to Miami for her case. She will be gone four to six
weeks. She came in early today because she does not have enough
medicine for four to six weeks. `` Id. Respondent issued B.B.
additional prescriptions for Dilaudid (and Soma) and indicated that
she would be seen again in a month. Id. Ten days later, B.B.
returned again to Respondent. Id. at 4. According to the progress
note, B.B. ``came early today because she will be evacuated from the
Fort Lauderdale area. No more court cases.'' Id. B.B. also told
Respondent that the pharmacy had called and told her that ``they
could not fill the prescription, because it was unreadable,'' (as if
the pharmacy would not have called Respondent to verify the script)
and that B.B. ``could not get the prescription back from the
pharmacy, so she does not have any medicine [because] she had to
leave it in Fort Lauderdale.'' Id.
---------------------------------------------------------------------------
Discussion
Section 304(a) of the Controlled Substances Act (CSA) provides that
a registration to ``dispense a controlled substance* * * may be
suspended or revoked by the Attorney General upon a finding that the
registrant* * * has committed such acts as would render his
registration under section 823 of this title inconsistent with the
public interest as determined under such section.'' 21 U.S.C. Sec.
824(a)(4) (emphasis added). With respect to a practitioner, the Act
requires the consideration of the following factors in making the
public interest determination:
(1) The recommendation of the appropriate State licensing board
or professional disciplinary authority.
(2) The applicant's experience in dispensing* * * controlled
substances.
(3) The applicant's conviction record under Federal or State
laws relating to the manufacture, distribution, or dispensing of
controlled substances.
(4) Compliance with applicable State, Federal, or local laws
relating to controlled substances.
(5) Such other conduct which may threaten the public health and
safety.
Id. Sec. 823(f).
[T]hese factors are * * * considered in the disjunctive.'' Robert
A. Leslie, M.D., 68 FR 15227, 15230 (2003). It is well settled that I
``may rely on any one or a combination of factors, and may give each
factor the weight [I] deem[] appropriate in determining whether a
registration should be revoked.'' Id.; Hoxie v. DEA, 419 F.3d 477, 482
(6th Cir. 2005). Moreover, I am ``not required to make findings as to
all of the factors.'' See Hoxie, 419 F.3d at 482; see also Morall v.
DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005).59
As explained below, I adhere to my initial findings regarding
factors one through four. As found in the original Order, the State of
Florida took no action against Respondent's state medical license and
Respondent has not been convicted of an offense under either Federal or
State laws relating to controlled substances. 71 FR at 52158-59. DEA
has long held, however, that a State's failure to take action against a
registrant's medical license is not dispositive in determining whether
the continuation of a registration is in the public interest. See,
e.g., Mortimer B. Levin, 55 FR 8209, 8210 (1990) (holding that
practitioner's reinstatement by state board ``is not dispositive'';
``DEA maintains a separate oversight responsibility with respect to the
handling of controlled substances and has a statutory obligation to
make its independent determination as to whether the granting of [a
registration] would be in the public interest''). Nor is the fact that
a registrant/applicant has not been convicted of a controlled substance
offense dispositive of whether the continuation of her registration is
in the public interest. See also Edmund Chein, 72 FR 6580, 6593 n.22
(2007).
Pursuant to the Court of Appeals' judgment, I have re-considered
the additional evidence pertaining to Respondent's ``positive
experience.'' Having done so, I again conclude that Respondent violated
Federal law and regulations in issuing the prescriptions to the
undercover operatives. I also conclude that Respondent violated Federal
law and regulations when she pre-signed prescriptions (which she gave
to her nurse) and delegated to him her authority to prescribe
controlled substances, even though he was not registered to prescribe
under Federal law and could not lawfully prescribe controlled
substances under state law. I therefore conclude that Respondent
committed acts inconsistent with the public interest and which support
the suspension or revocation of her registration. 21 U.S.C. 824(a)(4).
However, Respondent has now credibly acknowledged that her
prescribing to the undercover operatives and her pre-signing of the
prescriptions was improper. She has also credibly stated that she has
not engaged in such conduct since the events at issue here and has
promised that she will not do so in the future.\4\ I therefore further
conclude that Respondent has accepted responsibility for her misconduct
and can be entrusted with a new registration subject to the condition
agreed to by the parties.
---------------------------------------------------------------------------
\4\ In the original Order, I acknowledged that Respondent had
undertaken substantial measures to reform her practice. 71 FR at
52156 & 52159.
---------------------------------------------------------------------------
Factor Two and Four--Respondent's Experience in Dispensing Controlled
Substances and Record of Compliance With Applicable Controlled
Substance Laws
Under a longstanding DEA regulation, a prescription for a
controlled substance is not ``effective'' unless it is ``issued for a
legitimate medical purpose by an individual practitioner acting in the
usual course of his professional practice.'' 21 CFR 1306.04(a). Under
the CSA, it is fundamental that a practitioner must establish a
bonafide doctor-patient relationship in order to act ``in the usual
course of * * * professional practice'' and to issue a prescription for
a ``legitimate medical
[[Page 462]]
purpose.'' See United States v. Moore, 423 U.S. 122 (1975); see also 21
CFR 1306.04(a) (``an order purporting to be a prescription issued not
in the usual course of professional treatment * * * is not a
prescription within the meaning and intent of [21 U.S.C. 829] and * * *
the person issuing it, shall be subject to the penalties provided for
violations of the provisions of law related to controlled
substances'').
As the Supreme Court recently explained, ``the prescription
requirement* * * ensures patients use controlled substances under the
supervision of a doctor so as to prevent addiction and recreational
abuse. As a corollary, [it] also bars doctors from peddling to patients
who crave the drugs for those prohibited uses.'' Gonzales v. Oregon,
546 U.S. 243, 274 (2006) (citing Moore, 423 U.S. 122, 135 & 143
(1975)).
In this matter, the Government's presentation largely focused on
two allegations: (1) That Respondent lacked a legitimate purpose in
issuing the prescriptions to the undercover operatives, and (2) that
Respondent pre-signed blank prescriptions which she gave to her nurse
and allowed him to prescribe drugs even though the nurse was not
authorized under either Federal or State law to prescribe controlled
substances.
Whether this conduct is evaluated under factor two--the experience
factor, or factor four--the compliance factor, or both, is of no legal
consequence. In establishing its prima facie case, the fundamental
question is whether Respondent ``has committed such acts as would
render [her] registration * * * inconsistent with the public
interest.'' 21 U.S.C. 824(a)(4). As explained above, this Agency has
long held--and other courts of appeals have at least implicitly
recognized--that findings under a single factor are sufficient to
support the revocation of a registration. See Hoxie, 419 F.3d at 482;
Morall, 412 F.3d at 173-74.
In short, this is not a contest in which score is kept; the Agency
is not required to mechanically count up the factors and determine how
many favor the Government and how many favor the registrant. Rather, it
is an inquiry which focuses on protecting the public interest; what
matters is the seriousness of the registrant's misconduct.\5\
---------------------------------------------------------------------------
\5\ The Court of Appeals interpreted my prior decision as
``[b]alancing the factors and according `dispositive' weight to
factor five.'' Slip. Op. at 5. This suggests that the factors that
favored Respondent's continued registration (factors one and three)
were in equipoise with the factors that did not support her
continued registration. They were not. As explained above, even if
Respondent's conduct had been discussed under a single factor, the
conduct still would have established a prima facie case that her
continued registration was inconsistent with the public interest.
Factor five was dispositive because once the Government established
a prima facie case, the burden shifted to the Respondent to
demonstrate that her continued registration was consistent with the
public interest.
---------------------------------------------------------------------------
As previously found, on three separate occasions, undercover
operatives went to Respondent seeking prescriptions for controlled
substances. Each of the operatives stated that they were not in pain
and that they had been obtaining controlled substances from such non-
legitimate sources as a ``girlfriend'' (first visitor), ``a friend''
(second visitor) and ``a family member who has a prescription'' (third
visitor). 71 FR at 52150, 52152, and 52154. Respondent did not perform
a physical examination on any of the three operatives, even though she
acknowledged that performing a physical exam ``is the standard of
practice'' and ``our Rule No.1.'' Id. at 52154. Moreover, she falsified
each operative's medical record to indicate that she had performed a
physical exam. Id. at 52150 (first visitor), 52153 (second visitor), &
52154 (third visitor).
Most significantly, Respondent's statements as recorded on the wire
amply demonstrate that she knew that the operatives were seeking the
drugs not for the purpose of treating a legitimate medical condition,
but to abuse them. See 71 FR at 52150 (stating to first visitor: ``this
is a shame * * * that you have to take the medicine for the habit,''
``you can tell me that you want to come out of drugs''); id. at 52152
(asking second visitor: ``you don't have pain but you are taking
vicodin?'' and do you ``want to go to substance abuse program or do you
want to be maintained on the vicodin?''); id. (stating to second
visitor: ``maybe I'm sympathetic to the people that allow themselves to
slip into drugs''); id. at 52154 (during visit of third operative, when
asked by her nurse, ``what's the source of the pain?'', replying: ``I
guess he feels no pain, he just feels better.''); id. (stating to third
visitor: ``we will not be supporting just a drug habit'').
In various briefs, Respondent maintains that at the time of the
search, she had already discharged 6 of the 12 patients ``for various
reasons including non-compliance with the Prescription Pain Medication
Agreement, criminal acts or arrest.'' Resp. Exceptions to ALJ Dec. at
42. She contends that this is exculpatory evidence of her intent to not
improperly prescribe drugs. Id.
As found above, it is true that five of the patients whose files
were seized had been discharged before the search was conducted. Yet
even assuming that this evidence is relevant as to Respondent's intent
with respect to her prescribings to the undercover operatives, it is
not more probative of her intent during the visits than the evidence as
to what actually occurred during those visits. Indeed, even if the
operatives' initial statements to Respondent were ambiguous as to why
they were seeking the drugs, Respondent did not perform a physical exam
on any of the operatives (yet falsified the records to indicate that
she had done so) and her subsequent statements during the visits made
clear that she had resolved any doubt as to why the operatives were
seeking the drugs. In short, the evidence is clear that Respondent
issued prescriptions to each of the undercover operatives knowing that
they were seeking controlled substances for the purpose of abusing them
and not to treat a legitimate medical condition.\6\ I thus conclude
that Respondent lacked a legitimate medical purpose and thus violated
Federal law and DEA regulations when she issued the prescriptions to
the undercover operatives.
---------------------------------------------------------------------------
\6\ I acknowledge that some courts allow a defendant in criminal
matters to admit evidence of her ``prior good acts'' to prove she
lacked criminal intent. See United States v. Thomas, 134 F.3d 975,
979 (9th Cir. 1998); United States v. Garvin, 565 F.2d 519, 521-22
(8th Cir. 1977). Putting aside that this is not a criminal
proceeding and the Federal Rules of Evidence do not apply,
Respondent made no showing that the factual circumstances
surrounding her discharging of these patients were similar to the
circumstances involved in the undercover visits. Indeed, in four of
the five instances, the patients had been caught by others engaging
in problematic behavior such as criminal acts present altering or
photocopying prescriptions, (K.L. and J.B.), that the patient was
receiving drugs from another clinic (J.L.), or a report from the
patient's mother that he was abusing drugs (R.S.). RX 21, at 4, 23,
24 and 34.
---------------------------------------------------------------------------
In her exceptions, Respondent argued that ``her treatment of each
of the [twelve] patients [whose files were seized] was proper,'' and
that the ``Government presented no evidence suggesting that the
treatment of those twelve patients was anything but proper.'' Id.
Respondent also contends that she ``properly treated thousands of
patients for chronic pain,'' and that ``the Government was unable to
present any evidence that there was any problem with any non-undercover
patient.'' Id. at 64. Relatedly, the Court of Appeals has instructed
that the experience factor be reconsidered ``pay[ing] particular
attention to the entire corpus of Petitioner's record in dispensing
controlled substances.'' Slip Op. at 3.
As stated above, for the purpose of resolving this matter, I have
assumed that Respondent's prescribings of
[[Page 463]]
controlled substances to every other person she has treated constitute
``positive experience.'' Her prescribings to thousands of other
patients do not, however, render her prescribings to the undercover
officers any less unlawful, or any less acts which ``are inconsistent
with the public interest.'' 21 U.S.C. Sec. 823(f).
In enacting the CSA, Congress recognized that ``[m]any of the drugs
included within [the CSA] have a useful and legitimate medical purpose
and are necessary to maintain the health and general welfare of the
American people.'' 21 U.S.C. 801(1). Moreover, under the CSA, a
practitioner is not entitled to a registration unless she ``is
authorized to dispense * * * controlled substances under the laws of
the State in which [she] practices.'' 21 U.S.C. 823(f). Because under
law, registration is limited to those who have authority to dispense
controlled substances in the course of professional practice, and
patients with legitimate medical conditions routinely seek treatment
from licensed medical professionals, every registrant can undoubtedly
point to an extensive body of legitimate prescribing over the course of
her professional career.
Thus, in past cases, this Agency has given no more than nominal
weight to a practitioner's evidence that he has dispensed controlled
substances to thousands of patients in circumstances which did not
involve diversion. See, e.g., Caragine, 63 FR at 51599 (``[T]he
Government does not dispute that during Respondent's 20 years in
practice he has seen over 15,000 patients. At issue in this proceeding
is Respondent's controlled substance prescribing to 18 patients.'');
id. at 51600 (``[E]ven though the patients at issue are only a small
portion of Respondent's patient population, his prescribing of
controlled substances to these individuals raises serious concerns
regarding [his] ability to responsibly handle controlled substances in
the future.'').
While in Caragine, my predecessor did consider ``that the patients
at issue ma[de] up a very small percentage of Respondent's total
patient population,'' he also noted--in contrast to the prescribings at
issue here--``that [those] patients had legitimate medical problems
that warranted some form of treatment.'' Id. at 51601. Moreover, in
contrast to this case, in Caragine, there was no evidence that the
practitioner had intentionally diverted. Id. See also Medicine Shoppe--
Jonesborough, 73 FR 364, 386 & n.56 (2008) (noting that pharmacy ``had
17,000 patients,'' but that ``[n]o amount of legitimate dispensings can
render * * * flagrant violations [acts which are] `consistent with the
public interest.' ''), aff'd, Medicine Shoppe-Jonesborough v. DEA,
slip. op. at 11 (6th Cir. Nov. 13, 2008). Indeed, DEA has revoked other
practitioners' registrations for committing as few as two acts of
diversion. See Alan H. Olefsky, 57 FR 928, 928-29 (1992) (revoking
registration based on physician's presentation of two fraudulent
prescriptions to pharmacy and noting that the respondent ``refuses to
accept responsibility for his actions and does not even acknowledge the
criminality of his behavior''). See also Sokoloff v. Saxbe, 501 F.2d
571, 576 (2d Cir. 1974) (upholding revocation of practitioner's
registration based on nolo contendere plea to three counts of unlawful
distribution).
Accordingly, evidence that a practitioner has treated thousands of
patients does not negate a prima facie showing that the practitioner
has committed acts inconsistent with the public interest. While such
evidence may be of some weight in assessing whether a practitioner has
credibly shown that she has reformed her practices, where a
practitioner commits intentional acts of diversion and insists she did
nothing wrong, such evidence is entitled to no weight. As I held in the
original decision, I again conclude that Respondent's dispensings to
the undercover officers and her pre-signing of prescriptions and
unlawful delegation of her prescribing authority to her nurse,
establish a prima facie case that her continued registration is
``inconsistent with the public interest.''
Under longstanding Agency precedent, where, as here, ``the
Government has proved that a registrant has committed acts inconsistent
with the public interest, a registrant must `present sufficient
mitigating evidence to assure the Administrator that [he] can be
entrusted with the responsibility carried by such a registration.' ''
Medicine Shoppe, 73 FR at 387 (quoting Samuel S. Jackson, 72 FR 23848,
23853 (2007) (quoting Leo R. Miller, 53 FR 21931, 21932 (1988))).
``Moreover, because `past performance is the best predictor of future
performance,' ALRA Labs, Inc. v. DEA, 54 F.3d 450, 452 (7th Cir. 1995),
[DEA] has repeatedly held that where a registrant has committed acts
inconsistent with the public interest, the registrant must accept
responsibility for [her] actions and demonstrate that [she] will not
engage in future misconduct.'' Medicine Shoppe, 73 FR at 387; see also
Jackson, 72 FR at 23853; John H. Kennedy, 71 FR 35705, 35709 (2006);
Prince George Daniels, 60 FR 62884, 62887 (1995). See also Hoxie v.
DEA, 419 F.3d at 483 (``admitting fault'' is ``properly consider[ed]''
by DEA to be an ``important factor[]'' in the public interest
determination).
In this matter, I previously revoked Respondent's registration
because notwithstanding all of the measures she had undertaken to
reform her practice, she was the person with the prescribing authority
and had refused to acknowledge her responsibility under the law. 71 FR
at 52159. Had this case come back to me with the same evidentiary
record as before, I would again revoke her registration. Respondent,
however, has now acknowledged wrongdoing with respect to both her
prescribings to the undercover operatives, as well as her pre-signing
of prescriptions and delegation of her prescribing authority to her
nurse, who could not legally prescribe a controlled substance under
either the CSA or Florida Law. Moreover, Respondent's registration was
effectively suspended for a period of approximately one year. I
therefore conclude that the parties' proposed resolution of this matter
is in the public interest.
* * * * *
The diversion of controlled substances has become an increasingly
grave threat to this nation's public health and safety. According to
The National Center on Addiction and Substance Abuse (CASA), ``[t]he
number of people who admit abusing controlled prescription drugs
increased from 7.8 million in 1992 to 15.1 million in 2003.'' National
Center on Addiction and Substance Abuse, Under the Counter: The
Diversion and Abuse of Controlled Prescription Drugs in the U.S. 3
(2005). Moreover, ``[a]pproximately six percent of the U.S. population
(15.1 million people) admitted abusing controlled prescription drugs in
2003, 23 percent more than the combined number abusing cocaine (5.9
million), hallucinogens (4.0 million), inhalants (2.1 million) and
heroin (328,000).'' Id. Relatedly, ``[b]etween 1992 and 2003, there has
been a * * * 140.5 percent increase in the self-reported abuse of
prescription opioids,'' and in the same period, the ``abuse of
controlled prescription drugs has been growing at a rate twice that of
marijuana abuse, five times greater than cocaine abuse and 60 times
greater than heroin abuse.'' Id. at 4.\7\
---------------------------------------------------------------------------
\7\ According to a recent newspaper article, ``[p]rescription
painkiller and anti-anxiety drugs now kill about 500 people a year
in the Tampa Bay area, triple the number killed by illegal drugs
such as cocaine and heroin.'' Chris Tisch & Abbie Vansickle, Deadly
Combinations, St. Petersburg Times (Feb. 17, 2008), at 1. This
article further noted that while at the time of publication, the
figures for the year 2007 were not complete, ``the area is on pace
for about 550 deaths,'' and that ``prescription drug overdoses are
likely to overtake car crashes as the leading cause of accidental
death.'' Id. In contrast, in 2006, 433 people died of prescription
drug overdoses, and in 2005, 339 died. Id. According to the Circuit
Judge who runs the Pinellas County drug court, ``This has become an
epidemic.'' Id.
---------------------------------------------------------------------------
[[Page 464]]
While some isolated decisions of this Agency may suggest that a
practitioner who committed only a few acts of diversion was entitled to
regain his registration even without having to accept responsibility
for his misconduct, see Anant N. Mauskar, 63 FR 13687, 13689 (1998),
the great weight of the Agency's decisions are to the contrary. In any
event, the increase in the abuse of prescription controlled substances
calls for a clarification of this Agency's policy. Because of the grave
and increasing harm to public health and safety caused by the diversion
of prescription controlled substances, even where the Agency's proof
establishes that a practitioner has committed only a few acts of
diversion, this Agency will not grant or continue the practitioner's
registration unless he accepts responsibility for his misconduct.\8\
Put another way, even where the Government proves only a few instances
of illegal prescribing in the ``entire corpus'' of a practitioner's
experience, the Government has nonetheless made out a prima facie case
and thus shifted the burden to the registrant to show why he should be
entrusted with a new registration.\9\
---------------------------------------------------------------------------
\8\ Depending upon the facts and circumstances, a registrant/
applicant may also be required to show what corrective measures he/
she has instituted to prevent such acts from re-occurring.
\9\ To the extent Mauskar, or any other decision of this Agency
suggests otherwise, it is overruled.
---------------------------------------------------------------------------
I have abided by the judgment of the Court of Appeals in this
matter. However, some may interpret the Court's decision as suggesting
that ``the entire corpus'' of a practitioner's record in dispensing
controlled substances can outweigh a practitioner's intentional acts of
diversion where DEA only proves that a few acts of diversion have
occurred.
The Court's decision was not published and the Court did not
instruct the Agency as to how much weight the entire corpus should be
given. Nor did the Court explain whether ``the entire corpus'' should
be considered as part of the Government's prima facie case, or as part
of the registrant's rebuttal of the Government's case.
DEA therefore does not interpret the decision as altering the
manner in which similar arguments have been dealt with in prior cases.
While such evidence may have some probative value, it does not negate a
prima facie showing that a registrant/applicant has committed acts that
are inconsistent with the public interest. It may, however, be entitled
to some weight in assessing whether a registrant/applicant has
demonstrated that she can be entrusted with a new registration where
the Government's proof is limited to relatively few acts and a
registrant puts forward credible evidence that she has accepted
responsibility for her misconduct.
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(f) &
824(a), as well as 28 CFR 0.100(b) & 0.104, I hereby order that the DEA
Certificate of Registration issued to Jayam Krishna-Iyer, M.D., be, and
it hereby is, suspended. I further order that the suspension shall be
retroactive and limited to the period beginning on October 2, 2006, and
ending on October 2, 2007, when her registration was restored pursuant
to the judgment of the Court of Appeals. I further order that the
application of Jayam Krishna-Iyer, M.D., for renewal of her
registration be, and it hereby is, granted subject to the condition
that she file monthly reports with the Special Agent in Charge (or his
designee) of the Miami Field Division for a period of one year. The
reports shall list all controlled substances prescribed by the
patient's name, the date, the name of the drug, its strength, the
quantity prescribed, and the number of refills authorized. The reports
shall be due no later than the tenth day of the subsequent month and
shall list all patients in alphabetical order.\10\ Failure to comply
with the terms of this Order shall be grounds for the suspension or
revocation of Respondent's registration. This Order is effective
immediately.
---------------------------------------------------------------------------
\10\ If a patient received multiple prescriptions, all
prescriptions issued to the patient within the calendar month shall
be listed before the prescriptions for the next patient are
reported.
Dated: December 19, 2008.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E8-31412 Filed 1-5-09; 8:45 am]
BILLING CODE 4410-09-P